PT Kalbe Farma Tbk.
IDX:KLBF.JK
Overview | Financials
Company Name | PT Kalbe Farma Tbk. |
Symbol | KLBF.JK |
Currency | IDR |
Price | 1,615 |
Market Cap | 74,682,747,328,000 |
Dividend Yield | 0% |
52-week-range | 1,375 - 1,795 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. - Vidjongtius |
Website | https://www.kalbe.co.id |
An error occurred while fetching data.
About PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD